Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
Columbia University · NCT03722537
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- November 14, 2019
- Record last updated
- April 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a study comparing the current standard of care surgical treatment to a newer surgical procedure involving the implantation of osteochondral allograft at the base of the thumb. Patients will be followed at 1, 3, 6 months and 1 year post-operatively.
Being studied: Osteochondral Allograft; Ligament Reconstruction Tendon Interposition
Conditions: Basal Joint Arthritis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years of age or older
- Indicated for operative management of basal joint arthritis
Exclusion Criteria
- Pregnant women/fetuses/neonates, prisoners
- Previously operated on for treatment of basal joint arthritis
Recruiting US locations
Columbia University Irving Medical Center
New York, NY 10032
Site contact: Melvin P Rossenwasser, MD
Study contacts (from the official record)
- Melvin P Rosenwasser, MD · 212-305-8036 · mpr2@cumc.columbia.edu
Similar studies in New York
All arthritis studies in New York →- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Flushing, NY + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Orchard Park, NY + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Brooklyn, NY + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Novartis Pharmaceuticals
- Location
- New York, NY + 10 other US sites
- Eligibility basics
- Ages 2–17